Completed NA INTERVENTIONAL 2-arm NCT01087086

Reduction of the Metabolic Syndrome in Navarra-Spain (RESMENA-S)

Reduction of the Metabolic Syndrome in Navarra-Spain (RESMENA-S) Through an Innovative Multidisciplinary Strategy Based on the Crononutrition and Dietary Training Concepts, in Addition to Both Dietary and Psychological Control

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra

Conditions Cardiovascular Disease Diabetes Metabolic Syndrome Obesity

Interventions American Heart Association Crononutrition

Updated 5 times since 2017 Last updated: May 11, 2016 Started: Jan 31, 2010 Primary completion: Dec 31, 2010 Completion: Nov 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Cardiovascular Disease and Diabetes and is currently completed. Clinica Universidad de Navarra, Universidad de Navarra leads this study, which shows 5 recorded versions since 2010 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Clinica Universidad de Navarra, Universidad de Navarra
Hospital of Navarra

Data source: Clinica Universidad de Navarra, Universidad de Navarra

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pamplona, Spain